This topic is now archived and is closed to further replies.


Mylan buys Merck generic drug unit for $6.6 billion

1 post in this topic

The Canonsburg-based company announced late Saturday that it was buying the generics arm of Germany-based Merck KGaA for $6.6 billion, a blockbuster deal that will triple Mylan's size and make it a major player overseas.

Share this post

Link to post
Share on other sites

  • Recently Browsing   0 members

    No registered users viewing this page.